scispace - formally typeset
W

Wolf K. Hofmann

Researcher at Charité

Publications -  30
Citations -  6126

Wolf K. Hofmann is an academic researcher from Charité. The author has contributed to research in topics: Leukemia & Myeloid leukemia. The author has an hindex of 19, co-authored 30 publications receiving 5780 citations. Previous affiliations of Wolf K. Hofmann include Humboldt University of Berlin & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

TL;DR: Stem cells from a donor who was homozygous for CCR5 delta32 were transplanted in a patient with acute myeloid leukemia and HIV-1 infection and the patient remained without viral rebound 20 months after transplantation and discontinuation of antiretroviral therapy.
Journal ArticleDOI

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells

TL;DR: EPC exhibit a high expression of angiogenic growth factors, which enhanced migration of mature endothelial cells and tissue resident cardiac progenitor cells, and the enhanced expression of cytokines may be a supportive mechanism to improve blood vessel formation and cardiac regeneration after cell therapy.
Journal ArticleDOI

Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization

TL;DR: It is shown that Foxo1 and Foxo3a are the most abundant Foxo isoforms in mature endothelial cells and that overexpression of constitutively active Foxo 1 or Foxo 3a, but not Foxo4, significantly inhibits endothelial cell migration and tube formation in vitro.
Journal ArticleDOI

HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes

TL;DR: Atorvastatin-mediated prevention of EPC senescence appears to be mediated by the regulation of various cell cycle proteins, and induction ofEPC proliferation by statins in vitro may importantly improve the functional activity of E PCs for potential cell therapy.